US-based West Pharmaceutical Services Inc. (NYSE: WST), a global company that provides innovative solutions for injectable drug administration, announced on Wednesday that its board of directors has approved a first-quarter 2022 dividend of USD0.18 per share.

The dividend will be paid on 2 February 2022, to shareholders of record as of 19 January 2022.

The company's board of directors authorised a share repurchase program for calendar-year 2022 of up to 650,000 shares of the company's common stock from time to time on the open market or in privately negotiated transactions, as permitted under Exchange Act Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions. The company said that the share repurchase program is expected to be completed by 31 December 2022. Its previously authorised share repurchase program expired on 31 December 2021.